On the other hand, carbamoylphosphate synthetase 1 (CPS1) deficiency for UCD or Mut0 mutation that results in no detectable methylmalonyl CoA mutase activity for MMA both have poor outcome, which may cause higher mortality rate in our study group. This evidence concerns the gene CPS1 and urea cycle disorder.